- Management to host conference call today, April 10, at 8.30 a.m. EDT
- RNA delivery business progressing with new collaborations, potential new applications
- Partnering of legacy assets underway as Company transitions to focused RNA delivery technology provider
- Achieved 85% reduction in net loss to CHF 3.9 million and eliminated financial debt
- Finished year with shareholders’ equity of CHF 6.5 million, improved by CHF 14.8 million
Altamira’s Senior Management will hold an investor call today, Wednesday, April 10, 2024, at 8:30 a.m. EDT to discuss its business update and full-year 2023 results.
- Event: Altamira Therapeutics Full Year 2023 Financial Results and Business Update Call
- Date: Wednesday, April 10, 2024
- Time: 8:30 am EDT
- Webcast URL: https://edge.media-server.com/mmc/p/ijjfu6tm
Registration for Call
https://register.vevent.com/register/BI2e385f19fe9e405ca2c190f33b9b8e34
- Upon registering you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.
- Select a method for joining the call.
- Dial-In: A dial in number and unique PIN are displayed to connect directly from your phone.
- Call Me: Enter your phone number and click “Call Me” for an immediate callback from the system. The call will come from a US number.
Conference Call Replay
A replay of the call will be available after the live event and accessible through the webcast link:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.